Clinical trial

Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients

NCT06068686

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-10-01

PhaseNA

Study timeline

Study start (actual)2022-10-01Date precision: day

Registry last updated2025-02-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

Vildagliptin 50 MGDRUG

Glimepiride 3 Mg Oral TabletDRUG · verified · RxNorm: glimepiride 3 MG Oral Tablet

Sponsors & collaborators

Damanhour Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06068686 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.